Quetiapine

Quetiapine: Drug Information

Quetiapine: Drug Information

Navigation
1. Drug Name
2. Pharmacological Class
3. Mechanism of Action
4. Indications
5. Dosage and Administration
6. Pharmacokinetics
7. Contraindications
8. Warnings and Precautions
9. Side Effects
10. Drug Interactions
11. Pregnancy and Lactation
12. Patient Counseling Information

1. Drug Name

Generic Name

Quetiapine

Brand Name(s)

  • Pakistan: Seroquel
  • India: Qutipin, Seroquel
  • US: Seroquel, Seroquel XR
  • UK: Seroquel, Seroquel XL

2. Pharmacological Class

Class

Atypical antipsychotic

Subclass

Dibenzothiazepine derivative

3. Mechanism of Action

Quetiapine acts by antagonizing multiple neurotransmitter receptors in the brain, including serotonin 5-HT2 and dopamine D2 receptors, contributing to its antipsychotic effects. It also has affinity for histamine H1 and adrenergic alpha1 receptors.

4. Indications

Primary Indications

  • Schizophrenia: Treatment of schizophrenia and maintenance therapy to prevent relapse.
  • Bipolar Disorder: Acute treatment of manic or mixed episodes, depressive episodes, and maintenance therapy for bipolar I disorder.
  • Major Depressive Disorder (MDD): Adjunctive therapy in patients with major depressive disorder.

Off-label Uses

  • Generalized Anxiety Disorder (GAD)
  • Post-traumatic Stress Disorder (PTSD)
  • Insomnia

5. Dosage and Administration

Standard Dosage

For schizophrenia:

  • Initial: 25 mg twice daily
  • Maintenance: 150-750 mg/day

For bipolar disorder:

  • Initial: 50 mg twice daily
  • Maintenance: 200-800 mg/day

For major depressive disorder (adjunctive):

  • Initial: 50 mg once daily
  • Maintenance: 150-300 mg/day

Route of Administration

Oral (tablets, extended-release tablets)

Special Populations

  • Pediatric: Safety and efficacy in children under 10 years of age have not been established.
  • Geriatric: Use with caution due to increased risk of cerebrovascular adverse reactions.

6. Pharmacokinetics

Absorption

Rapidly absorbed with peak plasma concentrations reached within 1.5 hours for immediate-release and 6 hours for extended-release formulations.

Distribution

Widely distributed in the body, with about 83% bound to plasma proteins.

Metabolism

Metabolized primarily in the liver by CYP3A4 enzyme to its active metabolite, norquetiapine.

Excretion

Excreted mainly in urine (73%) and feces (21%).

Half-life

The elimination half-life of quetiapine is approximately 7 hours, and for norquetiapine, it is about 12 hours.

7. Contraindications

  • Known hypersensitivity to quetiapine or any components of the formulation
  • Concurrent use with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole)

8. Warnings and Precautions

  • Increased mortality in elderly patients with dementia-related psychosis
  • Neuroleptic malignant syndrome (NMS)
  • Tardive dyskinesia
  • Hyperglycemia and diabetes mellitus
  • Orthostatic hypotension

9. Side Effects

Common Side Effects

  • Drowsiness
  • Dizziness
  • Dry mouth
  • Weight gain

Serious Side Effects

  • Extrapyramidal symptoms (EPS)
  • Hyperglycemia
  • Seizures

10. Drug Interactions

Major Interactions

  • Ketoconazole
  • Ritonavir

Moderate Interactions

  • Antihypertensive agents
  • Phenytoin

Minor Interactions

  • Alcohol
  • St. John's Wort

11. Pregnancy and Lactation

Pregnancy Category

Category C - Risk cannot be ruled out.

Breastfeeding Considerations

Not recommended during breastfeeding due to potential adverse effects on the infant.

12. Patient Counseling Information

  • Take as directed and do not exceed prescribed dose.
  • Avoid alcohol and be cautious with activities requiring mental alertness until the response to the medication is known.
  • Monitor for signs of high blood sugar (e.g., increased thirst, urination) and report to the healthcare provider.
  • Maintain a balanced diet and regular exercise to manage weight gain.

Post a Comment

Previous Post Next Post